| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0000084 | Mitotic s phase | Affects phenotype | PMID:30981936 |
| GO:0000278 | Mitotic cell cycle | Affects phenotype | PMID:30981936 |
| GO:0001958 | Endochondral ossification | Decreases phenotype | PMID:33367866 |
| GO:0006006 | Glucose metabolic process | Affects phenotype | PMID:37042841 |
| GO:0006641 | Triglyceride metabolic process | Affects phenotype | PMID:36764644 |
| GO:0006701 | Progesterone biosynthetic process | Increases phenotype | PMID:28282128 |
| GO:0006974 | Cellular response to dna damage stimulus | Increases phenotype | PMID:30981936 |
| GO:0008210 | Estrogen metabolic process | Affects phenotype | PMID:35503735 |
| GO:0008283 | Cell population proliferation | Decreases phenotype | PMID:33969458; PMID:35503735 |
| GO:0008923 | Lysine decarboxylase activity | Decreases phenotype | PMID:25264276 |
| GO:0016477 | Cell migration | Decreases phenotype | PMID:33969458 |
| GO:0032930 | Positive regulation of superoxide anion generation | Increases phenotype | PMID:26794138 |
| GO:0042554 | Superoxide anion generation | Increases phenotype | PMID:30981936 |
| GO:0044237 | Cellular metabolic process | Decreases phenotype | PMID:33969458 |
| GO:0045333 | Cellular respiration | Affects phenotype | PMID:35503735 |
| GO:0045444 | Fat cell differentiation | Increases phenotype | PMID:31812418; PMID:36764644 |
| GO:0048709 | Oligodendrocyte differentiation | Decreases phenotype | PMID:33969458 |
| GO:0051881 | Regulation of mitochondrial membrane potential | Affects phenotype | PMID:30981936 |
| GO:0052689 | Carboxylic ester hydrolase activity | Decreases phenotype | PMID:32511959 |
| GO:0071897 | Dna biosynthetic process | Affects phenotype | PMID:30981936; PMID:33969458 |
| GO:0097086 | Amniotic stem cell differentiation | Decreases phenotype | PMID:37027338 |
| GO:0140042 | Lipid droplet formation | Increases phenotype | PMID:36764644 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Increases phenotype | PMID:30981936 |
| GO:1903428 | Positive regulation of reactive oxygen species biosynthetic process | Increases phenotype | PMID:38603619 |
| GO:2000866 | Positive regulation of estradiol secretion | Increases phenotype | PMID:38603619 |
| GO:2000872 | Positive regulation of progesterone secretion | Increases phenotype | PMID:26794138; PMID:38603619 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.